Kannaway’s Hemp Oil is derived from legal non-GMO European industrial hemp, utilizing our proprietary extraction methods to extract the hemp oil from the mature stalk. The key to our proprietary extraction method is to achieve an “essential plant complex”, which is rich in cannabinoids, terpenes, flavonoids, waxes and chlorophyll that are essential to the human body.
To ensure our products will meet the highest quality standards, each batch of hemp oil undergoes our Triple Lab Testing™, which includes 3 separate tests of your product between harvest and final packaging for sale. We were the first in the industry to create testing processes like these, ensuring that every natural product we offer is free of contaminants and of the highest quality possible.
BĬBONGLa tradizione Bĭbong® Bĭbong formulas are rooted in the teachings of the Royal Dr. Heo Jun of Korea. Jenelle Kim, Kannaway’s Formulator, is the gatekeeper of her lineage’s Bĭbong formulas; her lineage of herbologists and doctors were avid teachers of and adherents to the great Doctor Heo Jun. Dr. Heo Jun (1537/1539–1615) was the Court Physician of the Korean Joseon Dynasty.
Dr. Heo Jun compiled the Dongui Bogam, a 25-volume medical encyclopedia that was completed in 1613, with its basic theories based on the Yellow Emperors Inner Classic (Huangdi Neijing). This highly respected medical text is currently being studied at some of the most renowned medical universities, including Harvard Medical School.
The endocannabinoid system (ECS) is a group of endogenous cannabinoid receptors found in the brain of mammals, as well as in the central and peripheral nervous systems. It also includes neuromodulatory lipids and related receptors. ECS, the "body's own cannabinoid system", is involved in various physiological processes, including the mediation of appetite, pain, well-being, remembrance, and psychoactive effects of the cannabis plant. ECS also plays a role in shaping euphoric post-sporting activity.
Two main types were identified for endocannabinoid receptors: CB1 in 1990 and CB2 in 1993. CB1 receptors are primarily found in the brain, nervous system, and peripheral organs and tissues. CB1 is the major molecular target of endocannabinoid ligands (receptor-related molecules), which are the anandamide and the associated mimetic (mimetic) phytocannabinoid, THC. Another major endocannabinoid is 2-Arachidonoylglycerol (2-AG), which is active for both cannabinoid receptors and the associated mimetic phytocannabinoid CBD. 2-AG and CBD play a role in the mechanisms of control of appetite, immune function, and pain.
° With CBD Oil you can control the smooth functioning of the endocannabinoid system in the body.